Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (XVIPF)
:XVIPF
See the Price Targets and Ratings of:
XVIPF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Unknown Analyst
Not Ranked
Bryan Garnier & Co Ltd
$47.03
Hold
20.27%
Upside
Downgraded
07/15/24
Xvivo Perfusion downgraded to Neutral from Buy at Bryan GarnierXvivo Perfusion downgraded to Neutral from Buy at Bryan Garnier
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Unknown Analyst
Not Ranked
Bryan Garnier & Co Ltd
$47.03
Hold
20.27%
Upside
Downgraded
07/15/24
Xvivo Perfusion downgraded to Neutral from Buy at Bryan GarnierXvivo Perfusion downgraded to Neutral from Buy at Bryan Garnier
Best Analysts Covering Xvivo Perfusion AB
Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XVIPF Analyst Recommendation Trends
Rating
Jun 23
Jul 24
Strong Buy
1
1
Buy
0
0
Hold
0
1
Sell
0
0
Strong Sell
0
0
total
1
2
Each month's total comprises the sum of three months' worth of ratings.
XVIPF Stock Forecast FAQ
What is XVIPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Xvivo Perfusion AB’s 12-month average price target is $44.67.
What is XVIPF’s upside potential, based on the analysts’ average price target?
Xvivo Perfusion AB has 14.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is XVIPF a Buy, Sell or Hold?
Xvivo Perfusion AB has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Xvivo Perfusion AB’s price target?
The average price target for Xvivo Perfusion AB is $44.67. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $44.77 ,the lowest forecast is $44.77. The average price target represents 14.25% Increase from the current price of $39.1.
The highest analyst price target is $44.77 ,the lowest forecast is $44.77. The average price target represents 14.25% Increase from the current price of $39.1.
What do analysts say about Xvivo Perfusion AB?
Xvivo Perfusion AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of XVIPF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.